- Mazidi Sharafabadi F, Haleh Sadrzadeh Y, Hoseiyni M, Najarzadeh A, Mirzaian S. Relationships between weight gain during pregnancy and weight change one year after delivery compared with pre-pregnancy weight in Yazdi women. Iran J Diabetes Metab 2013; 12(4):335-44. (Persian).
- Stein TP, Scholl TO, Schluter MD, Schroeder CM. Plasma leptin influences gestational weight gain and postpartum weight retention. Am J Clin Nutr 1998; 68(6):1236-40.
- Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams obstetrics. New York: McGraw-Hill; 2010. P. 148.
- Schubring C, Kiess W, Englaro P, Rascher W, Dotsch J, Hanitsch S, et al. Levels of leptin in maternal serum, amniotic fluid, and arterial and venous cord blood: relation to neonatal and placental weight. J Clin Endocrinol Metab 1997; 82(5):1480-3.
- Kim KH, Kim YJ, Lee S, Oh SW, Lee K, Park Y, et al. Evaluation of plasma leptin levels & BMI as predictor of postpartum weight retention. Indian J Med Res 2008; 128(5):595-600.
- de Assis S, Wang M, Goel S, Foxworth A, Helferich W, Hilakivi-Clarke L. Excessive weight gain during pregnancy increases carcinogen-induced mammary tumorigenesis in Sprague-Dawley and lean and obese Zucker rats. J Nutr 2006; 136(4):998-1004.
- Khoshkam F, Taghian F, Jalali Dehkordi K. Effect of eight weeks of supplementation of omega-3 supplementation and TRX training on visfatin and insulin resistance in women with polycystic ovary syndrome. Iran J Obstet Gynecol Infertil 2018; 21(9):58-70. (Persian).
- Mashhad Taraqi AS, Tehranian N, Roudbaneh SP, Esmaeilzadeh MS, Kazemnejad A, Aghoozi MF, et al. Visfatin as a predictor for growth of fetus and infant. Turk J Obstet Gynecol 2018; 15(2):80-6.
- Saber A, Tehranian N, Pourali RS, Esmailzade MS. Role of visfatin in fertility and reproduction: a review study. J Sabzevar Univ Med Sci 2019; 25(6):829-44. (Persian).
- Berndt J, Klöting N, Kralisch S, Kovacs P, Fasshauer M, Schön MR, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 2005; 54(10):2911-6.
- Porter B, Babbar S, Ye SQ, Maulik D. The role of nicotinamide phosphoribosyltransferase in pregnancy: a review. Am J Perinatol 2016; 33(14):1327-36.
- Ognjanovic S, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002; 187(4):1051-8.
- Morgan SA, Bringolf JB, Seidel ER. Visfatin expression is elevated in normal human pregnancy. Peptides 2008; 29(8):1382-9.
- Kendal CE, Bryant-Greenwood GD. Pre-B-cell colony-enhancing factor (PBEF/visfatin) gene expression is modulated by NF-κB and AP-1 in human amniotic epithelial cells. Placenta 2007; 28(4):305-14.
- Ma Y, Cheng Y, Wang J, Cheng H, Zhou S, Li X. The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes. Diabetes Res Clin Pract 2010; 90(1):60-5.
- Luo JX, Liu XH, Zhang L, He GL. The expression of visfatin in placenta in women with gestational diabetes mellitus. Sichuan Da Xue Xue Bao Yi Xue Ban 2011; 42(2):204-7.
- Mazaki-Tovi S, Vaisbuch E, Romero R, Kusanovic JP, Chaiworapongsa T, Kim SK, et al. Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonate. J Matern Fetal Neonatal Med 2010; 23(10):1119-28.
- Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93(11 Suppl 1):S57-63.
- Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010; 11(1):11-8.
- Diamant M, Lamb HJ, van de Ree MA, Endert EL, Groeneveld Y, Bots ML, et al. The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes. J Clin Endocrinol Metab 2005; 90(3):1495-501.
- Bluher M. The distinction of metabolically ‘healthy' from ‘unhealthy' obese individuals. Curr Opin Lipidol 2010; 21(1):38-43.
- Kinoshita T, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: the ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest 2006; 61(2):115-8.
- Mazaki-Tovi S, Romero R, Kusanovic JP, Vaisbuch E, Erez O, Than NG, et al. Maternal visfatin concentration in normal pregnancy. J Perinat Med 2009; 37(3):206-17.
- Mazaki-Tovi S, Kasher-Meron M, Hemi R, Haas J, Gat I, Lantsberg D, et al. Chemerin is present in human cord blood and is positively correlated with birthweight. Am J Obstet Gynecol 2012; 207(5):412.e1-10.
- Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 2006; 49(8):1909-14.
- López-Bermejo A, Chico-Julià B, Fernàndez-Balsells M, Recasens M, Esteve E, Casamitjana R, et al. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 2006; 55(10):2871-5.
- Sandeep S, Velmurugan K, Deepa R, Mohan V. Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians. Metabolism 2007; 56(4):565-70.
- Zahorska-Markiewicz B, Olszanecka-Glinianowicz M, Janowska J, Kocelak P, Semik-Grabarczyk E, Holecki M, et al. Serum concentration of visfatin in obese women. Metabolism 2007; 56(8):1131-4.
- Kamińska A, Kopczyńska E, Bieliński M, Borkowska A, Junik R. visfatin concentrations in obese patients in relation to the presence of newly diagnosed glucose metabolism disorders. Endokrynol Pol 2015; 66(2):108-13.
- Nowak J, Kulik-Kupka K, Kowalska J, Zieleń-Zynek I, Hudzik B, Żyła A, et al. Visfatin concentration and anthropometric/biochemical parameters in healthy individuals-preliminary study. In20th European Congress of Endocrinology, Barcelona, Spain; 2018. P. 347.
- Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R, et al. Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans. J Clin Endocrinol Metab 2006; 91(8):3165-70.
- Lijun SU, Sun H, Hua S. Correlation between weight gain during late pregnancy and glycated Albumin, Visfatin level and neonatal body composition in gestational diabetes mellitus patients. J Pract Obstet Gynecol 2017; 33(3):194-7.
- Misra VK, Trudeau S, Perni U. Maternal serum lipids during pregnancy and infant birth weight: the influence of prepregnancy BMI. Obesity (Silver Spring) 2011; 19(7):1476-81.
- Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev 2000; 1(1):47-56.
- Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007; 50(4):938-48.
- Straughen JK, Trudeau S, Misra VK. Changes in adipose tissue distribution during pregnancy in overweight and obese compared with normal weight women. Nutr Diabetes 2013; 3:e84.
- Mastorakos G, Valsamakis G, Papatheodorou DC, Barlas I, Margeli A, Boutsiadis A, et al. The role of adipocytokines in insulin resistance in normal pregnancy: visfatin concentrations in early pregnancy predict insulin sensitivity. Clin Chem 2007; 53(8):1477-83.
- Esplin MS, Fausett MB, Peltier MR, Hamblin S, Silver RM, Branch DW, et al. The use of cDNA microarray to identify differentially expressed labor-associated genes within the human myometrium during labor. Am J Obstet Gynecol 2005; 193(2):404-13.
- Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Gotsch F, Mittal P, et al. Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition. J Perinat Med 2008; 36(6):485-96.
- Tehranian N, Pahlavan F, Tork TF, Asadi E. The relationship between adipokines and cytokines with postpartum depression: a systematic review. J Urmia Nurs Midwifery Facul 2017; 15(3):230-43. (Persian).
|